Clinical Trial Update: The Role of Metformin and Colesevelam in Human GLP-1 Secretion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining how metformin and colesevelam affect GLP-1 secretion in people with type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Colesevelam (colesevelam)
• metformin (metformin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED